Table 2.

Mean whole‐body fatty acid composition (%) of initial and fed Coppernose Bluegill reared in outdoor tanks at 0–16°C for 95 d. Treatment designations are as follows: initial (i) = fish acclimated to trial conditions but collected prior to the onset of feeding; 2×/week (8) = fish fed twice per week (i.e., 8×/month); 1×/week (4) = fish fed once per week (i.e., 4×/month); 2×/month (2) = fish fed twice per month; and 1×/month (1) = fish fed once per month. Values are least‐squares means (±SE) of 3–4 replicates/treatment. Within a given row, fatty acid means without a letter in common are significantly different (P ≤ 0.05).

Fatty acidaInitial (i)2×/week (8)1×/week (4)2×/month (2)1×/month (1)Pr > F
12:00.31 ± 0.03 z0.05 ± 0.04 y0.05 ± 0.04 y0.10 ± 0.04 y0.00 ± 0.05 y<0.001
14:02.78 ± 0.25 z1.52 ± 0.31 zy1.41 ± 0.31 y1.94 ± 0.31 zy1.15 ± 0.36 y0.011
15:01.41 ± 0.12 z0.67 ± 0.14 y0.63 ± 0.15 y0.84 ± 0.15 zy0.64 ± 0.17 y0.002
16:017.68 ± 1.1217.88 ± 1.3717.08 ± 1.3719.83 ± 1.3716.42 ± 1.580.574
17:01.75 ± 0.07 z1.44 ± 0.08 y1.43 ± 0.08 y1.75 ± 0.08 z1.60 ± 0.10 zy0.021
18:06.46 ± 0.226.90 ± 0.266.98 ± 0.266.59 ± 0.267.39 ± 0.310.174
19:01.01 ± 0.131.07 ± 0.161.14 ± 0.161.09 ± 0.161.19 ± 0.190.954
20:00.51 ± 0.050.54 ± 0.060.56 ± 0.060.63 ± 0.060.54 ± 0.070.714
21:02.91 ± 0.493.03 ± 0.603.26 ± 0.603.71 ± 0.603.26 ± 0.700.969
Sum of saturates34.84 ± 1.4833.10 ± 1.8232.54 ± 1.8236.49 ± 1.8232.18 ± 2.100.449
14:11.33 ± 0.180.83 ± 0.220.80 ± 0.221.14 ± 0.220.66 ± 0.250.188
16:18.73 ± 0.74 z4.94 ± 0.90 zy4.81 ± 0.90 y5.90 ± 0.90 zy3.88 ± 0.90 y0.012
18:1(n‐7) (VAC)11.30 ± 0.9810.24 ± 1.2010.49 ± 1.2011.62 ± 1.208.63 ± 1.380.492
18:1(n‐9)5.59 ± 0.28 z4.34 ± 0.34 zy4.16 ± 0.34 y4.81 ± 0.34 zy4.25 ± 0.39 zy0.027
20:11.43 ± 0.151.51 ± 0.191.59 ± 0.191.76 ± 0.191.58 ± 0.220.825
22:11.54 ± 0.301.65 ± 0.370.37 ± 0.370.85 ± 0.371.07 ± 0.420.166
24:12.63 ± 0.423.14 ± 0.522.52 ± 0.523.22 ± 0.523.54 ± 0.600.777
Sum of monoenes32.56 ± 1.7926.64 ± 2.1924.74 ± 2.1929.30 ± 2.1923.62 ± 2.530.059
18:2(n‐6) (LA)5.11 ± 0.42 y7.22 ± 0.52 z5.89 ± 0.52 zy5.59 ± 0.52 zy5.23 ± 0.60 zy0.044
18:3(n‐3) (ALA)1.47 ± 0.221.58 ± 0.271.69 ± 0.271.26 ± 0.271.73 ± 0.320.613
18:3(n‐6) (GLA)2.84 ± 0.182.25 ± 0.232.19 ± 0.232.68 ± 0.231.99 ± 0.260.062
20:21.31 ± 0.171.50 ± 0.211.59 ± 0.211.68 ± 0.211.55 ± 0.240.762
20:3 (all)2.25 ± 0.382.22 ± 0.472.23 ± 0.472.26 ± 0.473.01 ± 0.540.750
20:4 (ARA)3.66 ± 0.60 y6.26 ± 0.73 z7.14 ± 0.73 z5.54 ± 0.73 zy8.47 ± 0.85 z<0.001
20:5(n‐3) (EPA)2.56 ± 0.212.65 ± 0.262.90 ± 0.262.70 ± 0.263.15 ± 0.300.594
22:20.83 ± 0.400.71 ± 0.491.13 ± 0.490.30 ± 0.491.26 ± 0.570.718
22:42.28 ± 0.351.85 ± 0.432.38 ± 0.430.92 ± 0.431.49 ± 0.490.108
22:5(n‐3) (DPA)3.15 ± 0.293.62 ± 0.373.75 ± 0.373.63 ± 0.374.00 ± 0.410.523
22:6(n‐3) (DHA)6.36 ± 1.17 y9.36 ± 1.43 zy10.61 ± 1.43 z7.34 ± 1.43 zy11.01 ± 1.65 z0.018
PUFAs31.81 ± 2.30 y39.21 ± 2.81 z41.50 ± 2.81 z33.90 ± 2.81 zy42.86 ± 3.25 z0.032
Σn‐313.53 ± 1.57 y17.20 ± 1.92 zy18.95 ± 1.92 z14.92 ± 1.92 zy19.88 ± 2.21 z0.023
Σn‐618.28 ± 1.03 y22.01 ± 1.26 z22.55 ± 1.26 z18.98 ± 1.26 zy22.99 ± 1.46 z0.036
n‐6/n‐31.35 ± 0.101.38 ± 0.121.23 ± 0.121.31 ± 0.121.15 ± 0.140.710
Fatty acidaInitial (i)2×/week (8)1×/week (4)2×/month (2)1×/month (1)Pr > F
12:00.31 ± 0.03 z0.05 ± 0.04 y0.05 ± 0.04 y0.10 ± 0.04 y0.00 ± 0.05 y<0.001
14:02.78 ± 0.25 z1.52 ± 0.31 zy1.41 ± 0.31 y1.94 ± 0.31 zy1.15 ± 0.36 y0.011
15:01.41 ± 0.12 z0.67 ± 0.14 y0.63 ± 0.15 y0.84 ± 0.15 zy0.64 ± 0.17 y0.002
16:017.68 ± 1.1217.88 ± 1.3717.08 ± 1.3719.83 ± 1.3716.42 ± 1.580.574
17:01.75 ± 0.07 z1.44 ± 0.08 y1.43 ± 0.08 y1.75 ± 0.08 z1.60 ± 0.10 zy0.021
18:06.46 ± 0.226.90 ± 0.266.98 ± 0.266.59 ± 0.267.39 ± 0.310.174
19:01.01 ± 0.131.07 ± 0.161.14 ± 0.161.09 ± 0.161.19 ± 0.190.954
20:00.51 ± 0.050.54 ± 0.060.56 ± 0.060.63 ± 0.060.54 ± 0.070.714
21:02.91 ± 0.493.03 ± 0.603.26 ± 0.603.71 ± 0.603.26 ± 0.700.969
Sum of saturates34.84 ± 1.4833.10 ± 1.8232.54 ± 1.8236.49 ± 1.8232.18 ± 2.100.449
14:11.33 ± 0.180.83 ± 0.220.80 ± 0.221.14 ± 0.220.66 ± 0.250.188
16:18.73 ± 0.74 z4.94 ± 0.90 zy4.81 ± 0.90 y5.90 ± 0.90 zy3.88 ± 0.90 y0.012
18:1(n‐7) (VAC)11.30 ± 0.9810.24 ± 1.2010.49 ± 1.2011.62 ± 1.208.63 ± 1.380.492
18:1(n‐9)5.59 ± 0.28 z4.34 ± 0.34 zy4.16 ± 0.34 y4.81 ± 0.34 zy4.25 ± 0.39 zy0.027
20:11.43 ± 0.151.51 ± 0.191.59 ± 0.191.76 ± 0.191.58 ± 0.220.825
22:11.54 ± 0.301.65 ± 0.370.37 ± 0.370.85 ± 0.371.07 ± 0.420.166
24:12.63 ± 0.423.14 ± 0.522.52 ± 0.523.22 ± 0.523.54 ± 0.600.777
Sum of monoenes32.56 ± 1.7926.64 ± 2.1924.74 ± 2.1929.30 ± 2.1923.62 ± 2.530.059
18:2(n‐6) (LA)5.11 ± 0.42 y7.22 ± 0.52 z5.89 ± 0.52 zy5.59 ± 0.52 zy5.23 ± 0.60 zy0.044
18:3(n‐3) (ALA)1.47 ± 0.221.58 ± 0.271.69 ± 0.271.26 ± 0.271.73 ± 0.320.613
18:3(n‐6) (GLA)2.84 ± 0.182.25 ± 0.232.19 ± 0.232.68 ± 0.231.99 ± 0.260.062
20:21.31 ± 0.171.50 ± 0.211.59 ± 0.211.68 ± 0.211.55 ± 0.240.762
20:3 (all)2.25 ± 0.382.22 ± 0.472.23 ± 0.472.26 ± 0.473.01 ± 0.540.750
20:4 (ARA)3.66 ± 0.60 y6.26 ± 0.73 z7.14 ± 0.73 z5.54 ± 0.73 zy8.47 ± 0.85 z<0.001
20:5(n‐3) (EPA)2.56 ± 0.212.65 ± 0.262.90 ± 0.262.70 ± 0.263.15 ± 0.300.594
22:20.83 ± 0.400.71 ± 0.491.13 ± 0.490.30 ± 0.491.26 ± 0.570.718
22:42.28 ± 0.351.85 ± 0.432.38 ± 0.430.92 ± 0.431.49 ± 0.490.108
22:5(n‐3) (DPA)3.15 ± 0.293.62 ± 0.373.75 ± 0.373.63 ± 0.374.00 ± 0.410.523
22:6(n‐3) (DHA)6.36 ± 1.17 y9.36 ± 1.43 zy10.61 ± 1.43 z7.34 ± 1.43 zy11.01 ± 1.65 z0.018
PUFAs31.81 ± 2.30 y39.21 ± 2.81 z41.50 ± 2.81 z33.90 ± 2.81 zy42.86 ± 3.25 z0.032
Σn‐313.53 ± 1.57 y17.20 ± 1.92 zy18.95 ± 1.92 z14.92 ± 1.92 zy19.88 ± 2.21 z0.023
Σn‐618.28 ± 1.03 y22.01 ± 1.26 z22.55 ± 1.26 z18.98 ± 1.26 zy22.99 ± 1.46 z0.036
n‐6/n‐31.35 ± 0.101.38 ± 0.121.23 ± 0.121.31 ± 0.121.15 ± 0.140.710
a

Fatty acid classes and abbreviations are as follows: VAC = cis‐vaccenic acid; LA = linoleic acid; ALA = alpha‐linolenic acid; GLA = gamma‐linolenic acid; ARA = arachidonic acid; EPA = eicosapentaenoic acid; DPA = docosapentaenoic acid; DHA = docosahexaenoic acid; PUFAs = polyunsaturated fatty acids; Σn‐3 = sum of n‐3 fatty acids; Σn‐6 = sum of n‐6 fatty acids; and n‐6/n‐3 = ratio of Σn‐6 to Σn‐3.

Table 2.

Mean whole‐body fatty acid composition (%) of initial and fed Coppernose Bluegill reared in outdoor tanks at 0–16°C for 95 d. Treatment designations are as follows: initial (i) = fish acclimated to trial conditions but collected prior to the onset of feeding; 2×/week (8) = fish fed twice per week (i.e., 8×/month); 1×/week (4) = fish fed once per week (i.e., 4×/month); 2×/month (2) = fish fed twice per month; and 1×/month (1) = fish fed once per month. Values are least‐squares means (±SE) of 3–4 replicates/treatment. Within a given row, fatty acid means without a letter in common are significantly different (P ≤ 0.05).

Fatty acidaInitial (i)2×/week (8)1×/week (4)2×/month (2)1×/month (1)Pr > F
12:00.31 ± 0.03 z0.05 ± 0.04 y0.05 ± 0.04 y0.10 ± 0.04 y0.00 ± 0.05 y<0.001
14:02.78 ± 0.25 z1.52 ± 0.31 zy1.41 ± 0.31 y1.94 ± 0.31 zy1.15 ± 0.36 y0.011
15:01.41 ± 0.12 z0.67 ± 0.14 y0.63 ± 0.15 y0.84 ± 0.15 zy0.64 ± 0.17 y0.002
16:017.68 ± 1.1217.88 ± 1.3717.08 ± 1.3719.83 ± 1.3716.42 ± 1.580.574
17:01.75 ± 0.07 z1.44 ± 0.08 y1.43 ± 0.08 y1.75 ± 0.08 z1.60 ± 0.10 zy0.021
18:06.46 ± 0.226.90 ± 0.266.98 ± 0.266.59 ± 0.267.39 ± 0.310.174
19:01.01 ± 0.131.07 ± 0.161.14 ± 0.161.09 ± 0.161.19 ± 0.190.954
20:00.51 ± 0.050.54 ± 0.060.56 ± 0.060.63 ± 0.060.54 ± 0.070.714
21:02.91 ± 0.493.03 ± 0.603.26 ± 0.603.71 ± 0.603.26 ± 0.700.969
Sum of saturates34.84 ± 1.4833.10 ± 1.8232.54 ± 1.8236.49 ± 1.8232.18 ± 2.100.449
14:11.33 ± 0.180.83 ± 0.220.80 ± 0.221.14 ± 0.220.66 ± 0.250.188
16:18.73 ± 0.74 z4.94 ± 0.90 zy4.81 ± 0.90 y5.90 ± 0.90 zy3.88 ± 0.90 y0.012
18:1(n‐7) (VAC)11.30 ± 0.9810.24 ± 1.2010.49 ± 1.2011.62 ± 1.208.63 ± 1.380.492
18:1(n‐9)5.59 ± 0.28 z4.34 ± 0.34 zy4.16 ± 0.34 y4.81 ± 0.34 zy4.25 ± 0.39 zy0.027
20:11.43 ± 0.151.51 ± 0.191.59 ± 0.191.76 ± 0.191.58 ± 0.220.825
22:11.54 ± 0.301.65 ± 0.370.37 ± 0.370.85 ± 0.371.07 ± 0.420.166
24:12.63 ± 0.423.14 ± 0.522.52 ± 0.523.22 ± 0.523.54 ± 0.600.777
Sum of monoenes32.56 ± 1.7926.64 ± 2.1924.74 ± 2.1929.30 ± 2.1923.62 ± 2.530.059
18:2(n‐6) (LA)5.11 ± 0.42 y7.22 ± 0.52 z5.89 ± 0.52 zy5.59 ± 0.52 zy5.23 ± 0.60 zy0.044
18:3(n‐3) (ALA)1.47 ± 0.221.58 ± 0.271.69 ± 0.271.26 ± 0.271.73 ± 0.320.613
18:3(n‐6) (GLA)2.84 ± 0.182.25 ± 0.232.19 ± 0.232.68 ± 0.231.99 ± 0.260.062
20:21.31 ± 0.171.50 ± 0.211.59 ± 0.211.68 ± 0.211.55 ± 0.240.762
20:3 (all)2.25 ± 0.382.22 ± 0.472.23 ± 0.472.26 ± 0.473.01 ± 0.540.750
20:4 (ARA)3.66 ± 0.60 y6.26 ± 0.73 z7.14 ± 0.73 z5.54 ± 0.73 zy8.47 ± 0.85 z<0.001
20:5(n‐3) (EPA)2.56 ± 0.212.65 ± 0.262.90 ± 0.262.70 ± 0.263.15 ± 0.300.594
22:20.83 ± 0.400.71 ± 0.491.13 ± 0.490.30 ± 0.491.26 ± 0.570.718
22:42.28 ± 0.351.85 ± 0.432.38 ± 0.430.92 ± 0.431.49 ± 0.490.108
22:5(n‐3) (DPA)3.15 ± 0.293.62 ± 0.373.75 ± 0.373.63 ± 0.374.00 ± 0.410.523
22:6(n‐3) (DHA)6.36 ± 1.17 y9.36 ± 1.43 zy10.61 ± 1.43 z7.34 ± 1.43 zy11.01 ± 1.65 z0.018
PUFAs31.81 ± 2.30 y39.21 ± 2.81 z41.50 ± 2.81 z33.90 ± 2.81 zy42.86 ± 3.25 z0.032
Σn‐313.53 ± 1.57 y17.20 ± 1.92 zy18.95 ± 1.92 z14.92 ± 1.92 zy19.88 ± 2.21 z0.023
Σn‐618.28 ± 1.03 y22.01 ± 1.26 z22.55 ± 1.26 z18.98 ± 1.26 zy22.99 ± 1.46 z0.036
n‐6/n‐31.35 ± 0.101.38 ± 0.121.23 ± 0.121.31 ± 0.121.15 ± 0.140.710
Fatty acidaInitial (i)2×/week (8)1×/week (4)2×/month (2)1×/month (1)Pr > F
12:00.31 ± 0.03 z0.05 ± 0.04 y0.05 ± 0.04 y0.10 ± 0.04 y0.00 ± 0.05 y<0.001
14:02.78 ± 0.25 z1.52 ± 0.31 zy1.41 ± 0.31 y1.94 ± 0.31 zy1.15 ± 0.36 y0.011
15:01.41 ± 0.12 z0.67 ± 0.14 y0.63 ± 0.15 y0.84 ± 0.15 zy0.64 ± 0.17 y0.002
16:017.68 ± 1.1217.88 ± 1.3717.08 ± 1.3719.83 ± 1.3716.42 ± 1.580.574
17:01.75 ± 0.07 z1.44 ± 0.08 y1.43 ± 0.08 y1.75 ± 0.08 z1.60 ± 0.10 zy0.021
18:06.46 ± 0.226.90 ± 0.266.98 ± 0.266.59 ± 0.267.39 ± 0.310.174
19:01.01 ± 0.131.07 ± 0.161.14 ± 0.161.09 ± 0.161.19 ± 0.190.954
20:00.51 ± 0.050.54 ± 0.060.56 ± 0.060.63 ± 0.060.54 ± 0.070.714
21:02.91 ± 0.493.03 ± 0.603.26 ± 0.603.71 ± 0.603.26 ± 0.700.969
Sum of saturates34.84 ± 1.4833.10 ± 1.8232.54 ± 1.8236.49 ± 1.8232.18 ± 2.100.449
14:11.33 ± 0.180.83 ± 0.220.80 ± 0.221.14 ± 0.220.66 ± 0.250.188
16:18.73 ± 0.74 z4.94 ± 0.90 zy4.81 ± 0.90 y5.90 ± 0.90 zy3.88 ± 0.90 y0.012
18:1(n‐7) (VAC)11.30 ± 0.9810.24 ± 1.2010.49 ± 1.2011.62 ± 1.208.63 ± 1.380.492
18:1(n‐9)5.59 ± 0.28 z4.34 ± 0.34 zy4.16 ± 0.34 y4.81 ± 0.34 zy4.25 ± 0.39 zy0.027
20:11.43 ± 0.151.51 ± 0.191.59 ± 0.191.76 ± 0.191.58 ± 0.220.825
22:11.54 ± 0.301.65 ± 0.370.37 ± 0.370.85 ± 0.371.07 ± 0.420.166
24:12.63 ± 0.423.14 ± 0.522.52 ± 0.523.22 ± 0.523.54 ± 0.600.777
Sum of monoenes32.56 ± 1.7926.64 ± 2.1924.74 ± 2.1929.30 ± 2.1923.62 ± 2.530.059
18:2(n‐6) (LA)5.11 ± 0.42 y7.22 ± 0.52 z5.89 ± 0.52 zy5.59 ± 0.52 zy5.23 ± 0.60 zy0.044
18:3(n‐3) (ALA)1.47 ± 0.221.58 ± 0.271.69 ± 0.271.26 ± 0.271.73 ± 0.320.613
18:3(n‐6) (GLA)2.84 ± 0.182.25 ± 0.232.19 ± 0.232.68 ± 0.231.99 ± 0.260.062
20:21.31 ± 0.171.50 ± 0.211.59 ± 0.211.68 ± 0.211.55 ± 0.240.762
20:3 (all)2.25 ± 0.382.22 ± 0.472.23 ± 0.472.26 ± 0.473.01 ± 0.540.750
20:4 (ARA)3.66 ± 0.60 y6.26 ± 0.73 z7.14 ± 0.73 z5.54 ± 0.73 zy8.47 ± 0.85 z<0.001
20:5(n‐3) (EPA)2.56 ± 0.212.65 ± 0.262.90 ± 0.262.70 ± 0.263.15 ± 0.300.594
22:20.83 ± 0.400.71 ± 0.491.13 ± 0.490.30 ± 0.491.26 ± 0.570.718
22:42.28 ± 0.351.85 ± 0.432.38 ± 0.430.92 ± 0.431.49 ± 0.490.108
22:5(n‐3) (DPA)3.15 ± 0.293.62 ± 0.373.75 ± 0.373.63 ± 0.374.00 ± 0.410.523
22:6(n‐3) (DHA)6.36 ± 1.17 y9.36 ± 1.43 zy10.61 ± 1.43 z7.34 ± 1.43 zy11.01 ± 1.65 z0.018
PUFAs31.81 ± 2.30 y39.21 ± 2.81 z41.50 ± 2.81 z33.90 ± 2.81 zy42.86 ± 3.25 z0.032
Σn‐313.53 ± 1.57 y17.20 ± 1.92 zy18.95 ± 1.92 z14.92 ± 1.92 zy19.88 ± 2.21 z0.023
Σn‐618.28 ± 1.03 y22.01 ± 1.26 z22.55 ± 1.26 z18.98 ± 1.26 zy22.99 ± 1.46 z0.036
n‐6/n‐31.35 ± 0.101.38 ± 0.121.23 ± 0.121.31 ± 0.121.15 ± 0.140.710
a

Fatty acid classes and abbreviations are as follows: VAC = cis‐vaccenic acid; LA = linoleic acid; ALA = alpha‐linolenic acid; GLA = gamma‐linolenic acid; ARA = arachidonic acid; EPA = eicosapentaenoic acid; DPA = docosapentaenoic acid; DHA = docosahexaenoic acid; PUFAs = polyunsaturated fatty acids; Σn‐3 = sum of n‐3 fatty acids; Σn‐6 = sum of n‐6 fatty acids; and n‐6/n‐3 = ratio of Σn‐6 to Σn‐3.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close